Issue #20: Synthesis, Anticancer Evaluation, and Molecular Docking of Triazolylmethyl-Dihydroquinazolinyl Benzoate Derivatives as Potential PARP-1 Inhibitors.
Protein Design Digest - 2026-01-12 - Synthesis, Anticancer Evaluation, and Molecular Docking of Triazolylmethyl-Dihydroquinazolinyl Benzoate Derivatives as Potential PARP-1 Inhibitors.

Building something in Protein Design?
I love collaborating on new challenges. Let's build together.
Subscribe to Protein Design Digest
Daily curated signals from arXiv, PubMed, and BioRxiv.
Signal of the Day
Synthesis, Anticancer Evaluation, and Molecular Docking of Triazolylmethyl-Dihydroquinazolinyl Benzoate Derivatives as Potential PARP-1 Inhibitors.
Quinazolinone derivatives have emerged as promising scaffolds in medicinal chemistry due to their broad spectrum of biological activities, including anticancer potential. Incorporation of triazole rings through click chemistry has further boosted the pharmacological relevance of such compounds, due to the triazole’s stability, bioisosterism, and ability to engage in key interactions with biological targets. Motivated by these properties, a library of 24 triazolylmethyl-dihydroquinazolinyl benzoate (TDB) derivatives (7a-x) was synthesized using a click chemistry strategy, starting from anthranilamide and phthalic anhydride. The structures of the synthesized compounds were established through IR, 1 H NMR, 13 C NMR, and HRMS spectral analysis. The anticancer potential of all derivatives was evaluated by using SRB assay, with compounds 7j and 7q displaying notable activity, with GI 50 values of 22 and 48 µg/mL, respectively. In addition, compounds 7a, 7e, 7f, 7l, 7u, 7v, and 7x displayed moderate activity, with GI 50 values ranging from 58 to 77 µg/mL. In addition, molecular docking studies were performed using poly(ADP-ribose) polymerase-1 as the target enzyme, and the results confirmed that the TDB derivatives exhibited strong binding affinity. Furthermore, molecular dynamics simulations were conducted to evaluate the stability of the docked complexes, specifically for compounds 7j and 7q, which confirmed that the TDB derivatives formed stable interactions with poly(ADP-ribose) polymerase-1.
Why this matters: Provides actionable mutations to enhance catalytic efficiency or thermostability.
Also Worth Reading
Mechanisms of cellular senescence combined with molecular docking strategies: A biomarker study of potential therapeutic targets for allergic rhinitis.
Bioinformatics and molecular docking methods were used to screen potential biomarkers of cellular senescence in allergic rhinitis (Allergic rhinitis AR), which provided a theoretical basis for revealing the mechanism of AR and exploring new therapeutic approaches. Four AR-related gene chips (GSE19187, GSE43523, GSE44037, and GSE51392) were downloaded from the gene expression database (GEO) for data pooling. Screening differential genes (DEGs) were taken to intersect with cellular senescence-related genes (SRGs) to obtain differential senescence genes (DESRGs). The differential senescence genes were subjected to Gene Ontology Database (GO) functional analysis, Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway analysis, and GSEA enrichment analysis. Protein-protein interaction (PPI) networks were constructed through the STRING database, MCODE plugin weights were analyzed to identify important gene cluster modules, and Hub genes were screened using the CytoHubba plugin topological network algorithm. Hub gene protein interactions network (GeneMANIA) was constructed by the GeneMANIA database. Predict Hub gene construct mRNA-miNA-lncRNA interactions by miRanda, miRDB, miRWalk, TargetScan, and spongeScan databases; construct Hub gene transcription factor regulatory networks by TRRUST database; analyze Hub gene-drug interactions by DGIdb database and select commonly used drugs in the clinic for molecular docking validation. A total of 264 differential genes were screened in the training set with corrected P.adj < 0.05 and |log2FC| ≥ 1.2 as the filtering condition, and a total of 866 cellular senescence genes, and 20 differential senescence genes (DESRGs) were obtained by taking the intersection of the two. A total of 19 Hub genes were obtained after PPI analysis, which were CCL2, STAT1, TLR2, IGFBP3, TLR3, KLF4, IL1RN, IRF1, SERPINB2, DPP4, MME, NQO1, SAMHD1, XAF1, PHGDH, EIF4EBP1, CTH, HSPA2, AHR The gene-protein interaction network identified 19 Hub genes associated with 21 functional proteins. 5 of the Hub gene loci were associated with 29 miRNAs and 53 lncRNAs. The transcription factor regulatory network obtained 15 transcription factors capable of regulating Hub genes. The analysis of drug-gene interactions identified 489 drugs that target hub genes. For example, in the case of budesonide, the interacting genes STAT1, TLR2, TLR3, and AHR were selected for molecular docking. Similarly, for mometasone, the interacting genes TLR2 and CTH were chosen for molecular docking. Mining AR-related Hub senescence genes by bioinformatics analysis, constructing PPI network, ceRNA network, transcription factor regulatory network, gene-drug interaction network and molecular docking validation, we screened 19 CCL2, STAT1, TLR2, IGFBP3, TLR3, KLF4, IL1RN, IRF1, SERPINB2, DPP4, MME, NQO1, SAMHD1, XAF1, PHGDH, EIF4EBP1, CTH, HSPA2, and AHR are expected to be Hub genes for potential diagnostic and therapeutic biomarkers, which will provide targets and new insights for further in-depth explorations of AR cellular senescence-related mechanisms of action and therapy.
Integrating machine learning and molecular docking to elucidate the mechanism of atrial fibrillation induced by di(2-ethylhexyl) phthalate.
Environmental exposure is closely associated with the development of cardiovascular diseases. This study aims to explore the molecular mechanism by which Di (2-ethylhexyl) phthalate (DEHP) induces atrial fibrillation (AF). AF-related target genes were identified through differential expression analysis of multiple datasets. Machine learning algorithms, Weighted Gene Co-expression Network Analysis (WGCNA), Machine learning (ML) and molecular docking technology were integrated to investigate the binding interaction between DEHP and target proteins. A total of 8 potential key targets (ITGB2, ARPC1B, RYR2, FPR2, MPEG1, PRKCD, LCP1, RAC2) involved in DEHP-induced AF were identified. ML analysis confirmed these genes as core regulatory genes, among which ITGB2, ARPC1B, and RYR2 exhibited high diagnostic potential (Area Under the Receiver Operating Characteristic Curve, AUC ≥ 0.85). Molecular docking simulations showed stable binding specificity between DEHP and these core targets, with binding energies all below -3 kcal/mol. DEHP may promote AF pathogenesis by targeting specific genes and signaling pathways. DEHP has high binding affinity with ITGB2, ARPC1B, and RYR2, which may serve as targets for future interventions. These findings provide important insights into the in-depth exploration of the mechanism underlying DEHP-induced AF.
Mechanistic study of plastic monomers in gestational diabetes mellitus: A network toxicology and molecular docking approach.
Plastics are widely used in various fields such as food packaging, textile fibers, building materials, and transportation. Although the relationship between plastic additives and diseases has been reported, there is limited research on the association between plastic monomers (PM) and gestational diabetes mellitus (GDM). This study aims to investigate the link between environmental PM and GDM. By employing advanced network toxicology and molecular docking techniques, we successfully elucidated the molecular mechanisms by which PM may induce GDM. Utilizing databases such as PubChem, SEA, Super-PRED, SwissTargetPrediction, PharmMapper, Gene Cards, and OMIM, we identified potential targets associated with the disease. Further analysis using STRING and Cytoscape software helped determine the core targets most significantly related to these metabolic disorders. Additionally, Gene Ontology and Kyoto Encyclopedia of Genes and Genomes pathway enrichment analyses were conducted using the David database to characterize these core targets. Finally, molecular docking with CB-Dock2 was used to validate the binding affinity of PM to these target proteins. Our findings suggest that PM may potentially induce GDM by modulating the insulin signaling pathway through STAT3, AKT1, and TP53. In summary, this work provides novel insights into the mechanisms by which environmental pollutants may trigger GDM, thereby laying a theoretical foundation for disease prevention and treatment. It offers valuable references for the safety evaluation of plastics, urging food safety regulatory agencies to strengthen oversight and encouraging the public to reduce plastic usage.
Research & AI Updates
- AI: OpenAI leans into Healthcare with ChatGPT. RTZ #963 - AI: Reset to Zero — AI: OpenAI leans into Healthcare with ChatGPT.
From the Industry
- Biologics for bone regeneration: advances in cell, protein, gene, and mRNA therapies - Nature — Biologics for bone regeneration: advances in cell, protein, gene, and mRNA therapies Nature.
- Top 10 Biotech Startups In 2026 - inventiva.co.in — Top 10 Biotech Startups In 2026 inventiva.co.in.
- 1st biotech IPO of 2026 sees Aktis bring in $318M via upsized offering - Fierce Biotech — 1st biotech IPO of 2026 sees Aktis bring in $318M via upsized offering Fierce Biotech.
- Fierce Pharma Asia—China biotech deal spree rolls on; Shionogi buys Tanabe’s ALS business - Fierce Pharma — Fierce Pharma Asia—China biotech deal spree rolls on; Shionogi buys Tanabe’s ALS business Fierce Pharma.
- Aktis raises $318M in 2026’s first biotech IPO - BioPharma Dive — Aktis raises $318M in 2026’s first biotech IPO BioPharma Dive.
- Boltz takes off with $28M seed, partners with Pfizer on AI drug discovery - FirstWord — Boltz takes off with $28M seed, partners with Pfizer on AI drug discovery FirstWord.
- Boltz Bags $28M Funding and Pfizer Partnership for Biomolecular AI Boost - TechRepublic — Boltz Bags $28M Funding and Pfizer Partnership for Biomolecular AI Boost TechRepublic.
Quick Reads
Leveraging Consensus Docking Approaches for Human Mitochondrial Complexes I and III.
Although recent progress has been made, structure-based methods such as molecular docking are still underexplored in the context of toxicity prediction. Read more →
Mitigation conferred by banana flower extract against aflatoxin-induced oxidative stress, inflammation, apoptosis, molecular docking, and histological disturbances in rabbits.
This study investigated the protective effects of banana flower extract (BFE) against aflatoxin B1 (AFB1)-induced oxidative stress, inflammation, and immune dysfunction in growing rabbits. Read more →
Tensor-DTI: Enhancing Biomolecular Interaction Prediction with Contrastive Embedding Learning
Accurate drug-target interaction (DTI) prediction is essential for computational drug discovery, yet existing models often rely on single-modality predefined molecular descriptors or sequence-based embeddings with limited representativeness. Read more →
AI-driven <i>de novo</i> design of BRAF inhibitors with enhanced binding affinity and optimized drug-likeness.
Background Traditional drug discovery methods, such as high-throughput screening (HTS), are often inefficient and costly, especially in complex areas like oncology. Read more →
Emphasizing the role of oxidative stress and Sirt-1/Nrf2 and TLR-4/NF-κB in Tamarix aphylla mediated neuroprotective potential in rotenone-induced Parkinson’s disease: In silico and in vivo study.
Parkinson’s disease (PD) presents as a progressive deterioration of dopaminergic neurons, a process closely associated with increased oxidative damage due to accumulated reactive oxygen species, leading to weakened antioxidant defenses and ultimately neuronal dysfunction. Read more →
Decision Tree for Prediction of Binding Affinity.
Recent advances in machine learning methods indicate the adequacy of these approaches to build scoring functions to predict binding affinity. Read more →
Machine Learning for Protein Science and Engineering.
Recent years have seen significant breakthroughs at the intersection of machine learning and protein science. Read more →
Mechanistic study on the peripheral cannabinoid-1 receptor blockers based on the tricyclic scaffolds.
Cannabinoid-1 receptor (CB1R) is one of the promising targets for treating various diseases, various antagonists, agonists and reverse agonists targeting CB1R have been synthesized and investigated for clinical use. Read more →
Pipeline Tip
Check for missing residues in PDB files using PDB-Fixer before simulation.
Resources & Tools
- Dataset: UniRef - Clustered protein sequence sets for fast similarity searches.
- Dataset: BFD - Big Fantastic Database for deep learning protein modeling.
- Tool: RFdiffusion - State-of-the-art generative model for de novo protein design. View all tools →
- Tool: ProteinMPNN - High-speed sequence design optimized for fixed-backbone folding. View all tools →
- Event: Protein Design Hub (LinkedIn Group) (Ongoing)
- Event: Structural Biology Events (Open)
- Job: Clinical Bioinformatics Scientist - Indeed at Indeed Jobs
- Job: Bioinformatics engineer salary in Norristown, PA - Indeed at Indeed Jobs
The protein structure is the language of life; design is its poetry. — Recep Adiyaman